KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Total Debt Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -0.80%
Dec 31, 2025 -2.30%
Sep 30, 2025 1.73%
Jun 30, 2025 1.05%
Mar 31, 2025 1.25%
Dec 31, 2024 1.22%
Sep 30, 2024 14.79%
Jun 30, 2024 15.97%
Mar 31, 2024 56.05%
Dec 31, 2023 40.17%
Sep 30, 2023 38.77%
Jun 30, 2023 38.52%
Mar 31, 2023 37.49%
Dec 31, 2022 37.63%
Sep 30, 2022 35.87%
Jun 30, 2022 38.62%
Mar 31, 2022 39.76%
Dec 31, 2021 46.03%
Sep 30, 2021 45.65%
Jun 30, 2021 46.31%
Mar 31, 2021 47.19%
Dec 31, 2020 49.93%
Sep 30, 2020 43.94%
Jun 30, 2020 44.65%
Mar 31, 2020 44.33%
Dec 31, 2019 42.94%
Sep 30, 2019 26.62%
Jun 30, 2019 26.41%
Mar 31, 2019 -4.69%
Dec 31, 2018 -2.50%
Sep 30, 2018 0.26%
Jun 30, 2018 0.50%
Mar 31, 2018 -0.50%
Dec 31, 2017 1.49%
Sep 30, 2017 2.79%
Jun 30, 2017 8.58%
Mar 31, 2017 9.27%
Dec 31, 2016 4.09%
Sep 30, 2016 3.97%
Jun 30, 2016 4.07%
Mar 31, 2016 4.36%
Dec 31, 2015 4.20%
Dec 31, 2014 4.25%
Sep 30, 2014 3.07%
Jun 30, 2014 4.00%